PCSK9 Synthesis Inhibitor Shows Promise in Lowering LDL-C
A mean 51% reduction in low-density lipoprotein cholesterol was seen in the group assigned to the 300 mg dose of inclisiran.
Cholesterol
Antihypertensive Drugs and Statins Do Not Prevent Cognitive Decline
Antihypertensive drugs and rosuvastatin did not prevent or worsen cognitive decline in those at intermediate risk for CVD.
Both Low and High Levels of HDL Cholesterol Linked to Mortality Risk
Because of its association with conditions that increase both cardiovascular and non-cardiovascular mortality, HDL cholesterol’s role as an independently modifiable risk factor may be in question.
Are ACC/AHA Cholesterol Guidelines Correctly Applied in HIV Patient Populations?
Of patients with HIV who were statin-eligible, about 60% received a prescription.
Familial Hypercholesterolemia Screening for Children in Primary Care
The overall prevalence of familial hypercholesterolemia mutation was 1 in 273 children.
Cardiovascular Disease Risk in SLE Reduced With Prevention Counseling Program
More than 40% of patients with systemic lupus erythematosus (SLE) were not aware of the elevated CVD risk associated with the condition.
AHA Recommendations for Managing Statin Drug-Drug Interactions
The AHA released recommendations for managing potential statin drug-drug interactions with other therapies in patients with cardiovascular disease.
Metabolic Risk Factors for Diabetic Kidney Disease
High-density lipoprotein cholesterol 30%, albuminuria (24%) and developing 1 abnormality.
CVD Risk Management in Rheumatoid Arthritis: Updated Guidelines
The European League Against Rheumatism (EULAR) has released updated guidelines for cardiovascular disease risk assessment in patients with rheumatoid arthritis.
LDL Cholesterol Lowering Genetic Variants Increase Diabetes Risk
Low-density lipoprotein cholesterol-lowering genetic variants were associated with a higher risk of developing type 2 diabetes.
- Loading...
Loading...
Loading... 
Loading...